Applied DNA Sciences, Inc. (APDN)

USD 0.23

(1.26%)

Gross Profit Summary of Applied DNA Sciences, Inc.

  • Applied DNA Sciences, Inc.'s latest annual gross profit in 2023 was 5.53 Million USD , up 9.49% from previous year.
  • Applied DNA Sciences, Inc.'s latest quarterly gross profit in 2024 Q2 was 109.32 Thousand USD , down -52.69% from previous quarter.
  • Applied DNA Sciences, Inc. reported a annual gross profit of 5.05 Million USD in annual gross profit 2022, up 2.54% from previous year.
  • Applied DNA Sciences, Inc. reported a annual gross profit of 4.92 Million USD in annual gross profit 2021, up 307.1% from previous year.
  • Applied DNA Sciences, Inc. reported a quarterly gross profit of 231.09 Thousand USD for 2024 Q1, up 192.54% from previous quarter.
  • Applied DNA Sciences, Inc. reported a quarterly gross profit of 111.06 Thousand USD for 2024 Q3, up 124.31% from previous quarter.

Annual Gross Profit Chart of Applied DNA Sciences, Inc. (2023 - 1998)

Historical Annual Gross Profit of Applied DNA Sciences, Inc. (2023 - 1998)

Year Gross Profit Gross Profit Growth
2023 5.53 Million USD 9.49%
2022 5.05 Million USD 2.54%
2021 4.92 Million USD 307.1%
2020 1.21 Million USD -73.17%
2019 4.51 Million USD 67.31%
2018 2.69 Million USD -26.61%
2017 3.67 Million USD 6.81%
2016 3.43 Million USD -60.11%
2015 8.62 Million USD 216.92%
2014 2.72 Million USD 33.64%
2013 2.03 Million USD 9.79%
2012 1.85 Million USD 91.43%
2011 968.84 Thousand USD 112.04%
2010 456.91 Thousand USD 95.33%
2009 233.92 Thousand USD -66.66%
2008 701.67 Thousand USD 609.86%
2007 98.84 Thousand USD 2931.19%
2006 3261.00 USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%

Peer Gross Profit Comparison of Applied DNA Sciences, Inc.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD 42.155%
Prenetics Global Limited 8.82 Million USD 37.333%
Star Equity Holdings, Inc. 11.92 Million USD 53.602%
CareDx, Inc 178.32 Million USD 96.897%
Exact Sciences Corporation 1.84 Billion USD 99.7%
Exagen Inc. 29.45 Million USD 81.215%
Inotiv, Inc. 165.44 Million USD 96.655%
Guardant Health, Inc. 336.89 Million USD 98.358%
Biodesix, Inc. 36.07 Million USD 84.662%
BioNexus Gene Lab Corp. 1.32 Million USD -316.205%
Precipio, Inc. 6.01 Million USD 8.052%
iSpecimen Inc. 5.1 Million USD -8.331%
Natera, Inc. 492.74 Million USD 98.877%
Aspira Women's Health Inc. 5.26 Million USD -5.158%
Standard BioTools Inc. 50.45 Million USD 89.032%
23andMe Holding Co. 99.37 Million USD 94.432%
Castle Biosciences, Inc. 174.8 Million USD 96.835%
Personalis, Inc. 18.2 Million USD 69.61%
Aclaris Therapeutics, Inc. 13.16 Million USD 57.978%
OpGen, Inc. -90.69 Thousand USD 6201.211%
T2 Biosystems, Inc. -8.17 Million USD 167.729%
Myriad Genetics, Inc. 476.4 Million USD 98.838%
ICON Public Limited Company 1.81 Billion USD 99.695%
NeoGenomics, Inc. 244.6 Million USD 97.738%
Star Equity Holdings, Inc. 11.92 Million USD 53.602%
IDEXX Laboratories, Inc. 2.18 Billion USD 99.747%
RadNet, Inc. 93 Million USD 94.05%
MDxHealth SA 43.92 Million USD 87.404%
Psychemedics Corporation 8.41 Million USD 34.228%
Illumina, Inc. 2.74 Billion USD 99.798%
Check-Cap Ltd. -212 Thousand USD 2710.109%
Twist Bioscience Corporation 133.34 Million USD 95.85%
DarioHealth Corp. 5.98 Million USD 7.53%
Fulgent Genetics, Inc. 104.45 Million USD 94.703%
Sera Prognostics, Inc. 96 Thousand USD -5663.992%
ENDRA Life Sciences Inc. -275.45 Thousand USD 2108.863%
OPKO Health, Inc. 318.12 Million USD 98.261%
Medpace Holdings, Inc. 524.5 Million USD 98.945%
Neogen Corporation 463.9 Million USD 98.807%
Intelligent Bio Solutions Inc. 1.42 Million USD -288.141%
Prenetics Global Limited 8.82 Million USD 37.333%
Mainz Biomed B.V. 509.65 Thousand USD -985.713%
bioAffinity Technologies, Inc. 791.61 Thousand USD -599.005%
Trinity Biotech plc 19.45 Million USD 71.55%
Neuronetics, Inc. 51.7 Million USD 89.298%
Sotera Health Company 577.15 Million USD 99.041%
bioAffinity Technologies, Inc. 791.61 Thousand USD -599.005%